Aclarion, Inc. (ACON)
$2.14-4.89%Close
SELLCRISIS · day 11
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1M
- Beta
- 1.21
- P/E (TTM)
- -0.28
- Short % float
- 9.18%
- Days to cover
- 1.0
- SI change
- -35.6%
- 1W
- -6.55%
- 1M
- -17.05%
- vs SPY 1W
- -6.97%
- vs SPY 1M
- -19.11%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 13
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-35.6%
REV YoY-
ROE-59.3%
EPS YoY-
ROA-51.0%
GROSS-51
OP-11592
NET-10978
[VALUATION]
P/E TTM-0.28
P/E FWD-
SECTOR PE20.34
INDUSTRY PE24.21
P/B0.31
P/FCF-
EV/EBITDA1.13
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO16.20
ND/EBITDA-
BETA1.21
Company news
FAQ
- What is LOPJLB’s current signal on ACON?
- LOPJLB’s latest quantitative signal on Aclarion, Inc. (ACON) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ACON in?
- Aclarion, Inc. (ACON) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Aclarion, Inc. (ACON) do?
- Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to qu…